Plasma levels and activity of AAT are reported to be significantly decreased in DM patients [24]–[26], while we and others found urinary fragments of AAT to be significantly increased [27], suggesting increased degradation and subsequent renal clearance of AAT-derived peptides in DM. The gene discussed is SERPINA1; the disease is diabetes mellitus.